^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners

    TEST:
    DiviTum® TKa test

    Company:
    Biovica
    Type:
    Laboratory Developed Test

    Details

    Evidence
    News
    DiviTum® TKa is a blood-based biomarker test that monitors and predicts treatment response in hormone receptor-positive metastatic breast cancer. The test measures thymidine kinase activity (TKa) which reflects cell proliferation.
    Cancer:
    Hormone Receptor Positive Breast Cancer
    Gene:
    ER (Estrogen receptor), PGR (Progesterone receptor)
    Method:
    Blood-based biomarker test